News Article

Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor explore the intriguing applications of cerebral organoids in the latest edition of PharmaTimes.

These artificially grown minibrains have the potential to guide drug discovery, and lead to a powerful new generation of bio-computers and AI better able to mimic the human brain.